Searched for
SUPERBUGS ANTIBIOTIC DISCOVERY
Pharma in her DNA, Wockhardt scion ready for deep dive in the USZahabiya Khorakiwala is leading Wockhardt's US business and the launch of its new antibiotic, Zaynich. This drug targets resistant bacteria...
FDA approval puts Wockhardt’s Zaynich in $9 billion antibiotics marketWockhardt's new antibiotic, Zaynich, has received US FDA approval. This drug uses a novel mechanism to fight drug-resistant bacteria. It ta...
5,000-year-old bacteria revived from ice can fight superbugs, but scientists see a downsideScientists have isolated a Psychrobacter SC65A.3, a bacterial strain frozen for almost 5,000 years in Romania’s Scărișoara Ice Cave. The mi...
Scientists have found a powerful hidden antibiotic, and they are stunned by its discoveryScientists have discovered a potent new antibiotic, pre-methylenomycin C lactone, within a well-studied bacterium, Streptomyces coelicolor....
Artificial Intelligence designs two potential antibiotics to combat drug-Resistant Gonorrhoea and MRSAResearchers have used AI to design two promising antibiotics that are helpful in combating drug-resistant bacteria, including gonorrhoea an...
Wockhardt exits US generics biz to focus on drug discoveryWockhardt is set to exit its loss-making US generics business to prioritize innovation, focusing on new antibiotic drug discovery and its b...
Wockhardt activates Zaynich push, eyes global licensing dealsWockhardt is advancing Zaynich, a novel antibiotic combination, targeting drug-resistant infections, with plans for regulatory submissions ...
AI stuns scientists : Superbug mystery solved in 48 hours after decade long researchGoogle's AI tool, Co-Scientist, stunned researchers by solving a decade-old mystery about antibiotic-resistant superbugs in just 48 hours—s...
Can Zaynich do for Wockhardt what Ozempic did for Novo Nordisk?Wockhardt's Zaynich antibiotic surged stock by 75%. CEO Habil Khorakiwala cited its uniqueness; phase three trials end this fiscal year. Co...
Do you really need that antibiotic?Swallowing an antibiotic is like carpet-bombing the trillions of microorganisms that live in the gut, killing not just the bad but the good...
Oxford University's new mega centre to combat global antibiotic resistanceThe university experts warn that it is arguably the greatest economic and healthcare challenge facing the world post-Covid and therefore th...
COVID will soon be past episode of 21st century: Harsh VardhanThe process, which used to take 10 years to produce vaccines, is now done in almost 10 months, Vardhan said while addressing the Boston Cen...
At the epicenter of a war, Indian antibiotic startups are fighting back“We’re creating a bullet against organisms that are taking out humanity. Wouldn’t it be nice to get a battleground to test it on that’s rea...
Up in the air: Monitoring microbes"If you can prevent the spread from one region of the hospital to another, you would reduce the rate in which people pick up infection in t...
ET Startup Awards 2017: Both Bugworks Research & Pandorum Technologies grab 'Top Innovator' awardDespite the complexities, long durations and dearth of money required for such research, several young companies are making a global impact...
New incentives needed to develop antibiotics to fight superbugsAmerican military researchers on Thursday announced the first U.S. case of a patient with an infection found to be resistant to the antibio...
Why Indian startups like Bugworks, Vitas Pharma have entered the field of drug discoveryAcross geographies, big pharmaceutical companies seem to have stepped back from research and development (R&D) for new drug discovery in th...
- Superbug threat: Govt mulls introducing new 'schedule' in Act
The threat of a multi-drug resistant superbug looming large has forced the government to consider introduction of a separate schedule in th...
- Lancet says sorry for 'Delhi bug'
'It was unfair to name a superbug -- organisms that grow in nature in every country -- after India without any evidence that it originated ...
- For an HIV vaccine: Innovate organisation of research
Only 0.028% of India’s population is HIV positive, but the sheer size in absolute numbers makes them the world’s largest national contingen.